CHAG priming regimen containing of cytarabine, aclacinomycin homoharringtonine and G-CSF for relapsed refractory acute myelogenous leukemia: a modified combination chemotherapeutic combination.

Chen, Lin; Yin, Qingsong; Mi, Ruihua; Wei, Xudong

Chen, Lin; Yin, Qingsong; Mi, Ruihua; Wei, Xudong.

Affiliation

Chen L; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University , Zhengzhou , China.

Leuk Lymphoma ; 54(10): 2291-3, 2013 Oct.

Article in En | MEDLINE | ID: mdl-23369043

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Leukemia, Myeloid, Acute/drug therapy; Aclarubicin/administration & dosage; Aclarubicin/analogs & derivatives; Cytarabine/administration & dosage; Granulocyte Colony-Stimulating Factor/administration & dosage; Harringtonines/administration & dosage; Homoharringtonine; Humans; Leukemia, Myeloid, Acute/mortality; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Limits: Humans Language: En Journal: Leuk Lymphoma Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google